CoverageForm 410-K10-Q8-K13D13G13F

MYNZ Mainz Biomed N.V. - 8-K

Filed May 28, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-062109
8.01

Item 8.01 - Other Events

121 words

Item 8.01 Other Events.

On May 28, 2026, Quantum Cyber N.V. (the “Company”)
received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”)
stating that for the last 10 consecutive business days, from May 13, 2026, to May 27, 2026, the closing bid price of the Company’s
ordinary shares had been at or greater than $1.00 per share. Accordingly, the Company has regained compliance with Nasdaq Listing Rule
5550(a)(2).

As previously reported, on March 20, 2026, the
Company received a letter from Nasdaq notifying the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over
the previous 30 consecutive business days.

Per the Letter, the matter is now closed.

1